Through a series of in vitro and in vivo preclinical experiments, we have shown that DSP-7888 Emulsion, a WT1-based therapeutic cancer vaccine, can induce HLA-restricted WT1-specific cytotoxic T cells and helper T cells. The gene discussed is WT1; the disease is cancer.